Mean weight loss reached 14.9% compared to just 2.4% for placebo
19 pacientes reciban tenofovir, un frmaco de primera lnea para el tratamiento de la hepatitis crnica por virus B, tambin asociado con acidosis lctica
Your gastroenterologist and prescriber should review the specific combination you take
Instead, with proper treatment, it can stay at a low level that is easy to ignore
doi: 10.1007/S10741-024-10450-6 130 ZhaoXLiuYWangDLiTXuZLiZet al
15,226,227 Recent therapeutic approaches focus on aldose reductase inhibitors (ARIs), such as epalrestat and ranirestat, which have shown promise in reducing sorbitol accumulation and ameliorating neuropathic symptoms in clinical trials